Director Elizabeth Mora sells 300 MKS INC (MKSI) shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
MKS INC director Elizabeth Mora reported an open-market sale of company stock. She sold 300 shares of common stock at a price of $239.44 per share. After this transaction, she continued to hold 18,663.394 shares of MKS INC common stock directly.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan that she adopted on February 19, 2025, indicating the transaction was scheduled in advance rather than timed discretionarily.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 300 shares ($71,832)
Net Sell
1 txn
Insider
Mora Elizabeth
Role
Director
Sold
300 shs ($72K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 300 | $239.44 | $72K |
Holdings After Transaction:
Common Stock — 18,663.394 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did MKS INC (MKSI) report for Elizabeth Mora?
MKS INC director Elizabeth Mora reported selling 300 shares of common stock in an open-market transaction. The shares were sold at a price of $239.44 per share, as disclosed in the Form 4 insider trading report.
Is the Elizabeth Mora stock sale at MKS INC (MKSI) part of a 10b5-1 plan?
Yes. The filing states the transaction was executed under a Rule 10b5-1 trading plan adopted on February 19, 2025. Such plans allow insiders to schedule trades in advance to help manage compliance with insider trading rules.
What role does Elizabeth Mora hold at MKS INC (MKSI) in this Form 4 filing?
In the Form 4, Elizabeth Mora is identified as a director of MKS INC. She is not listed as an officer or 10% owner, and the reported transaction reflects her activity as a board member holding common stock directly.
What type of transaction code appears in Elizabeth Mora’s MKS INC (MKSI) Form 4?
The transaction is coded "S" for a sale in open-market or private transactions. It involves non-derivative common stock, indicating a straightforward sale of existing shares rather than an exercise, conversion, or derivative-related transaction.